Theolytics ^Companies

Theolytics is a clinical stage biotechnology company based in England. They are focused on developing next-generation viral therapies to combat disease. The company utilizes a phenotypic screening platform to discover and develop targeted candidates suitable for intravenous delivery. Theolytics is advancing an internal pipeline of programs for both solid and liquid tumors, while also establishing strategic partnerships to accelerate pipeline development. Their goal is to transform patients' lives through innovative therapies and world-leading science.